Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure
Author: ["Mary Tang","Guang Wang","Ping Lu","Richard H Karas","Mark Aronovitz","Scott P Heximer","Kevin M Kaltenbronn","Kendall J Blumer","David P Siderovski","Yan Zhu","Michael E Mendelsohn"]
Publication: Nature Medicine
CITE.CC academic search helps you expand the influence of your papers.
Abstract
Nitric oxide (NO) inhibits vascular contraction by activating cGMP-dependent protein kinase I-α (PKGI-α), which causes dephosphorylation of myosin light chain (MLC) and vascular smooth muscle relaxation. Here we show that PKGI-α attenuates signaling by the thrombin receptor protease-activated receptor-1 (PAR-1) through direct activation of regulator of G-protein signaling-2 (RGS-2). NO donors and cGMP cause cGMP-mediated inhibition of PAR-1 and membrane localization of RGS-2. PKGI-α binds directly to and phosphorylates RGS-2, which significantly increases GTPase activity of Gq, terminating PAR-1 signaling. Disruption of the RGS-2–PKGI-α interaction reverses inhibition of PAR-1 signaling by nitrovasodilators and cGMP. Rgs2−/− mice develop marked hypertension, and their blood vessels show enhanced contraction and decreased cGMP-mediated relaxation. Thus, PKGI-α binds to, phosphorylates and activates RGS-2, attenuating receptor-mediated vascular contraction. Our study shows that RGS-2 is required for normal vascular function and blood pressure and is a new drug development target for hypertension.
Cite this article
Tang, M., Wang, G., Lu, P. et al. Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med 9, 1506–1512 (2003). https://doi.org/10.1038/nm958